CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart drug shows promise in Real-World chinese study
Disease control CompletedThis study looked at how well the drug vericiguat works for Chinese adults with chronic heart failure (a condition where the heart doesn't pump blood well). Researchers compared 2400 patients taking vericiguat to similar patients receiving standard care. The goal was to see if ve…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Disease control
Last updated May 17, 2026 06:15 UTC
-
Heart failure drug vericiguat tested in Real-World german patients
Disease control CompletedThis study looked at data from 500 people in Germany with chronic heart failure who were prescribed vericiguat. Researchers wanted to see how well the drug works in real life, not just in a controlled trial. They measured deaths and hospital stays related to heart failure. The go…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Heart failure drug shows promise in major trial
Disease control CompletedThis study tested a drug called vericiguat in over 6,000 adults with chronic heart failure and a weak heart pump. The goal was to see if it could lower the chance of dying from heart problems or being hospitalized for heart failure. Participants took the drug or a placebo along w…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Can a higher starting dose of vericiguat help heart failure patients faster?
Symptom relief CompletedThis study looked at whether people with chronic heart failure can safely start taking vericiguat at a 5 mg dose instead of the usual 2.5 mg. The goal is to reach the full 10 mg target dose more quickly. 106 participants took the 5 mg dose for 2 weeks, and researchers monitored s…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Bayer • Aim: Symptom relief
Last updated May 07, 2026 18:38 UTC
-
Japanese heart failure patients under the microscope: Vericiguat's Real-World impact revealed
Knowledge-focused CompletedThis study looked at nearly 5,000 Japanese adults with chronic heart failure who started taking the drug vericiguat as part of their regular care. Researchers used hospital records to track outcomes like death, heart-related hospital stays, and how long patients stayed on the med…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 17, 2026 06:22 UTC